Laerdal Million Lives Fund
VC Fund
San Francisco, United States
Laerdal Million Lives Fund is a venture capital firm that focuses on investments in life-saving technologies. Its investment thesis aims to contribute to Laerdal’s impact goal of helping save 1 million lives annually by 2030. The firm targets investments in commercial-stage technologies that address mortality rates across clinical areas, such asmaternal, neonatal, emergency medicine, critical care, surgery, and others and provide better medical education and training to providers and patients.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 11%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Laerdal Million Lives Fund invests in
Stages Laerdal Million Lives Fund invests in
Countries Laerdal Million Lives Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Becca Shmukler
|
|||
Jacob Johnson
|
|||
Jeff Trost
|
|||
2 more contacts available
Investment Focus
Industry
- Health Care 11 (58%)
- Medical 6 (32%)
- Medical Device 6 (32%)
- mHealth 2 (11%)
- Wellness 2 (11%)
Stage
- Series B 6 (32%)
- Series A 5 (26%)
- Series C 3 (16%)
- Seed 2 (11%)
- Pre-Seed 2 (11%)
Country
- United States 11 (58%)
- Nigeria 2 (11%)
- Israel 1 (5%)
- Switzerland 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Becca Shmukler
Principal
|
Principal | Total investments: 1 | Find email | |
|
Jacob Johnson
Principal
|
Principal | Total investments: 0 | Find email | |
|
Jeff Trost
Managing Partner
|
Managing Partner | Total investments: 7 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pharaoh Neuro
|
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients. | $20M / Series A / Feb 18, 2026 | |
Sovato Health
|
Sovato Health provides surgical access through remote robotic surgeon options. | $41M / Series B / Nov 04, 2025 | |
CorFlow Therapeutics
|
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients. | $48.5M / Series B / Sep 10, 2024 | |
Novocuff
|
Novocuff is a medical device firm that aims to improve pregnancy outcomes and reduce preterm deliveries caused by PPROM and cervical shortening. | $26M / Series A / Jul 17, 2024 | |
Boulder Care
|
Boulder is a digital health platform expanding access to effective treatment for opiate use. We aim to move the behavioral health industry forward by offering dramatically better experiences for patients and their care teams. | $35M / Series C / May 21, 2024 | |
Ciconia Medical
|
Maternal health medical device | $125K / Pre-Seed / Mar 05, 2024 | |
Avive Solutions
|
Avive Solutions develops a next-generation Automated External Defibrillator (AED) and software solutions. Avive's AED enables anyone to positively impact the outcome of a Sudden Cardiac Arrest (SCA) rescue by building a more robust solution that addresses the problem of SCA in its entirety. The AED will remove barriers to respond to a SCAscenario. It will be easy to purchase, easy to access in an emergency, easy to keep maintained, and most importantly easy to use effectively when it matters most.Avive Solutions is headquartered in San Francisco, California. | $56.5M / Series B / Feb 14, 2024 | |
AMOpportunities
|
AMOpportunities connects international medical students and graduates with U.S. physicians and institutions for clinical experiences. The company's platform offers individuals the opportunity to explore and apply for clinical experiences at 200+ clinical sites across 70+ medical specialties and subspecialties. AMO provides exceptionalsupport services such as visa and housing assistance.It was founded in 2013 and based in Chicago, Illinois. | $2M / Series A / Aug 02, 2023 | |
Cardiosense
|
Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease. | $15.1M / Series A / Dec 08, 2022 | |
|
Boulder Care
|
Boulder is a digital health platform expanding access to effective treatment for opiate use. We aim to move the behavioral health industry forward by offering dramatically better experiences for patients and their care teams. | $36M / Series B / Jun 10, 2022 | |
| See all 19 investments → | |||
Co-Investors
Picus Capital
4 deals together
AXA Investment Managers
2 deals together
Broadview Ventures
2 deals together
C5 Capital
2 deals together
Catalyst Health Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Laerdal Million Lives Fund invest in?
Laerdal Million Lives Fund invests primarily in Health Care, Medical and Medical Device startups, most often at Series B and Series A stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Laerdal Million Lives Fund?
Public channels for Laerdal Million Lives Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Laerdal Million Lives Fund?
The team at Laerdal Million Lives Fund includes Becca Shmukler (Principal), Jacob Johnson (Principal) and Jeff Trost (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
